Author

Yanling Zhao

Baylor College of MedicineORCID 0000-0002-7706-880XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Brian R. RoodiD· 1 shared Cheng FengiD· 1 shared Chunchao ZhangiD· 1 shared Dan QiiD· 1 shared Daniel Silverman· 1 shared Erxi WuiD· 1 shared Jeffrey S. DomeiD· 1 shared Jianhua YangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brian R. RoodORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 19, 2024

CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in Neuroblastoma

Yang Yu, Yanling Zhao, Zhongcheng Shi…·Jianhua Yang

This study identifies CAMKV kinase signaling as a critical driver of neuroblastoma growth and shows it as a potential therapeutic target and prognostic marker.

DOI 10.1101/2024.02.19.581040

humanproteomics

𝕏 PostBluesky